CHF 4226 pMDI

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF 4226 pMDI, covering 2009-03-27 to 2009-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers [Phase 1]